The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy

BJU International

Volumn 105, Issue 12, 2010, Pages 1646-1649

  Barlow, Lamont J ^a   Badalato, Gina M ^a   Bashir, Talha ^a   Benson, Mitchell C ^a   McKiernan, James M ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Age factors; Prostate cancer; Prostate specific antigen; Prostatectomy; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; GLEASON SCORE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATECTOMY; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE;

ADULT; AGE FACTORS; AGED; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT FAILURE;

EID: 77952845310     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08977.x     Document Type: Article

References (9)

1. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998 90 : 766 771
2. Grossfeld GD, Latini DM, Lubeck DP, Metha SS, Carroll PR. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol 2003 169 : 157 163
3. Kupelian P, Katcher J, Levin H, Zippe C, Klein E. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology 1996 48 : 249 260
4. Freedland SJ, Terris MK, Csathy GS et al. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol 2004 171 : 2215 2220
5. Haukaas S, Halvorsen OK, Daehlin L, Hostmark J, Akslen LA. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer? BJU Int 2006 97 : 51 5
6. Sun L, Moul JW, Hotaling JM et al. Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. BJU Intl 2007 99 : 753 757
7. Peschel RE, Khan A, Colberg J, Wilson LD. The effect of age on prostate implantation results. Cancer J 2006 12 : 305 308
8. Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beamradiation. J Urol 2002 168 : 536 541
9. Roach M III, Lu J, Pilepich MV et al. Long-term survival after radiotherapy alone: Radiation Therapy Oncology Group prostate cancer trials. J Urol 1999 161 : 864 868